Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-15-036519
Filing Date
2015-06-10
Accepted
2015-06-10 16:51:47
Documents
2
Period of Report
2015-06-08

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v412876_3.html 3  
1 OWNERSHIP DOCUMENT v412876_3.xml 3 1566
2 EXHIBIT 24 v412876_ex-24.htm EX-24 6757
  Complete submission text file 0001144204-15-036519.txt   9641
Mailing Address 12325 EMMET STREET OMAHA NE 68164
Business Address 12325 EMMET ST OMAHA NE 68164 4027385480
TRANSGENOMIC INC (Issuer) CIK: 0001043961 (see all company filings)

EIN.: 911789357 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments

Mailing Address C/O TRANSGENOMIC, INC. 12325 EMMET STREET OMAHA NE 68164
Business Address
Thomae Mya (Reporting) CIK: 0001644663 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36439 | Film No.: 15923912